A citation-based method for searching scientific literature


List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Improved bioavailability of a water-insoluble drug by inhalation of drug-containing maltosyl-β-cyclodextrin microspheres using a four-fluid nozzle spray drier.
Tetsuya Ozeki, Yoshihito Kano, Norimitsu Takahashi, Tatsuaki Tagami, Hiroaki Okada. AAPS PharmSciTech 2012
4
100

Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide.
P Uhl, C Grundmann, M Sauter, P Storck, A Tursch, S Özbek, K Leotta, R Roth, D Witzigmann, J A Kulkarni,[...]. Nanomedicine 2020
14
100

Nanoemulsion: for improved oral delivery of repaglinide.
Juber Akhtar, Hefazat Hussain Siddiqui, Sheeba Fareed, Badruddeen, Mohammad Khalid, Mohammed Aqil. Drug Deliv 2016
19
100

Amylin agonists: a novel approach in the treatment of diabetes.
Ole Schmitz, Birgitte Brock, Jorgen Rungby. Diabetes 2004
117
100

Concomitant use of miglitol and mitiglinide as initial combination therapy in type 2 diabetes mellitus.
Fuminori Tatsumi, Mitsuru Hashiramoto, Hidenori Hirukawa, Tomohiko Kimura, Masashi Shimoda, Kazuhito Tawaramoto, Yukiko Kanda-Kimura, Takatoshi Anno, Fumiko Kawasaki, Tomoatsu Mune,[...]. Diabetes Res Clin Pract 2013
7
100

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.
Ildiko Lingvay, Andrei-Mircea Catarig, Juan P Frias, Harish Kumar, Nanna L Lausvig, Carel W le Roux, Desirée Thielke, Adie Viljoen, Rory J McCrimmon. Lancet Diabetes Endocrinol 2019
63
100

Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Xiaoxuan Li, Xuefei Huang, Chongfei Bai, Dalian Qin, Shousong Cao, Qibing Mei, Yun Ye, Jianming Wu. Front Pharmacol 2018
9
100


Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect.
Junko Hanato, Kazuki Kuriyama, Takahiro Mizumoto, Kazuhiro Debari, Junya Hatanaka, Satomi Onoue, Shizuo Yamada. Int J Pharm 2009
21
100

Effects of linagliptin monotherapy compared with voglibose on postprandial blood glucose responses in Japanese patients with type 2 diabetes: Linagliptin Study of Effects on Postprandial blood glucose (L-STEP).
Yoshio Fujitani, Shimpei Fujimoto, Kiyohito Takahashi, Hiroaki Satoh, Takahisa Hirose, Toru Hiyoshi, Masumi Ai, Yosuke Okada, Masahiko Gosho, Tomoya Mita,[...]. Diabetes Res Clin Pract 2016
7
100

Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats.
Robert B Jones, Steven P Vickers, Sharon C Cheetham, Katie R Headland, Michael Mark, Thomas Klein. Eur J Pharmacol 2014
8
100


Treatment strategies against diabetes: Success so far and challenges ahead.
Rubiya Khursheed, Sachin Kumar Singh, Sheetu Wadhwa, Bhupinder Kapoor, Monica Gulati, Rajan Kumar, Arya Kadukkattil Ramanunny, Ankit Awasthi, Kamal Dua. Eur J Pharmacol 2019
31
100

Development of solid lipid nanoparticles as carriers for improving oral bioavailability of glibenclamide.
L M D Gonçalves, F Maestrelli, L Di Cesare Mannelli, C Ghelardini, A J Almeida, P Mura. Eur J Pharm Biopharm 2016
34
100

Retrospective comparison of voglibose or acarbose as an add-on therapy to sulfonylureas in Western Indian patients with uncontrolled overweight/obese type 2 diabetes.
Praful A Talaviya, Banshi D Saboo, Hardik G Dodiya, Shaival K Rao, Shashank R Joshi, Vipul B Modh, Sneha V Ghadiya. Diabetes Metab Syndr 2016
5
100

Empagliflozin in combination with oral agents in young and overweight/obese Type 2 diabetes mellitus patients: A pooled analysis of three randomized trials.
Irene Romera, Ramon Gomis, Susanne Crowe, Pedro de Pablos-Velasco, Unai Aranda, Arantxa García, Sanja Giljanovic Kis, Ebrahim Naderali. J Diabetes Complications 2016
6
100

Comparison of pre- versus post-meal administration of voglibose in men with or without impaired glucose tolerance.
Kazutaka Aoki, Yuzuru Ito, Kaori Saito, Jun Shirakawa, Yu Togashi, Kouichiro Satoh, Tomonori Muraoka, Kazuaki Shinoda, Kiyomi Masuda, Mari Kimura,[...]. Diabetes Res Clin Pract 2009
7
100

Sulfonylureas and their use in clinical practice.
Daniele Sola, Luca Rossi, Gian Piero Carnevale Schianca, Pamela Maffioli, Marcello Bigliocca, Roberto Mella, Francesca Corlianò, Gian Paolo Fra, Ettore Bartoli, Giuseppe Derosa. Arch Med Sci 2015
156
100

Dynamics of diabetes and obesity: Epidemiological perspective.
Annette Boles, Ramesh Kandimalla, P Hemachandra Reddy. Biochim Biophys Acta Mol Basis Dis 2017
73
100



Type 2 diabetes mellitus: a review of current trends.
Abdulfatai B Olokoba, Olusegun A Obateru, Lateefat B Olokoba. Oman Med J 2012
381
100

Phenformin as an Anticancer Agent: Challenges and Prospects.
Mª Eugenia García Rubiño, Esmeralda Carrillo, Gloria Ruiz Alcalá, Alicia Domínguez-Martín, Juan A Marchal, Houria Boulaiz. Int J Mol Sci 2019
21
100



Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
Bernard Zinman, Stewart B Harris, Jan Neuman, Hertzel C Gerstein, Ravi R Retnakaran, Janet Raboud, Ying Qi, Anthony J G Hanley. Lancet 2010
154
100

Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Noritsugu Wada, Katsuhito Mori, Chie Nakagawa, Jun Sawa, Yasuro Kumeda, Tetsuo Shoji, Masanori Emoto, Masaaki Inaba. J Diabetes Complications 2015
17
100

Functional alterations of intestinal P-glycoprotein under diabetic conditions.
Takuro Kobori, Shinichi Harada, Kazuo Nakamoto, Shogo Tokuyama. Biol Pharm Bull 2013
15
100

Lower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysis.
Zachary T Bloomgarden, Regina Dodis, Catherine M Viscoli, Eric S Holmboe, Silvio E Inzucchi. Diabetes Care 2006
177
100

Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study.
Angelo Maria Patti, Dragana Nikolic, Antonio Magan-Fernandez, Rosaria Vincenza Giglio, Giuseppa Castellino, Roberta Chianetta, Roberto Citarrella, Egle Corrado, Francesca Provenzano, Vincenzo Provenzano,[...]. Diabetes Res Clin Pract 2019
13
100

α-Glucosidase inhibitors and their use in clinical practice.
Giuseppe Derosa, Pamela Maffioli. Arch Med Sci 2012
126
100

Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial - START Study.
T V Devarajan, S Venkataraman, Narayanan Kandasamy, Abraham Oomman, Hari Kishan Boorugu, S K P Karuppiah, Dushyant Balat. Indian J Endocrinol Metab 2017
6
100

Sodium-glucose Cotransporter-2 Inhibitors in Combination with Other Glucose-lowering Agents for the Treatment of Type 2 Diabetes Mellitus.
Sanjay Kalra, Jothydev Kesavadev, Manoj Chadha, G Vijaya Kumar. Indian J Endocrinol Metab 2018
6
100


Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.
Eliana B Souto, Selma B Souto, Joana R Campos, Patricia Severino, Tatiana N Pashirova, Lucia Y Zakharova, Amélia M Silva, Alessandra Durazzo, Massimo Lucarini, Angelo A Izzo,[...]. Molecules 2019
32
100




Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release.
Sandeep Kumar, Gaurav Bhanjana, Ritesh Kumar Verma, Dinesh Dhingra, Neeraj Dilbaghi, Ki-Hyun Kim. J Pharm Pharmacol 2017
20
100



Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
Takahiro Yajima, Kumiko Yajima, Makoto Hayashi, Hiroshi Takahashi, Keigo Yasuda. Diabetes Res Clin Pract 2016
12
100

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and concomitant heart failure.
Mikhail Kosiborod, Ingrid Gause-Nilsson, John Xu, Christian Sonesson, Eva Johnsson. J Diabetes Complications 2017
24
100

Recent advances in nanotechnology for diabetes treatment.
Rocco Michael DiSanto, Vinayak Subramanian, Zhen Gu. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2015
37
100

Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population.
Rana Moustafa Al AdAwi, Zainab Jassim, Dina Elgaily, Hani Abdelaziz, Bhagya Sree, Mohamed Izham Mohamed Ibrahim. Sci Rep 2019
4
100

Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management.
Arun Chaudhury, Chitharanjan Duvoor, Vijaya Sena Reddy Dendi, Shashank Kraleti, Aditya Chada, Rahul Ravilla, Asween Marco, Nawal Singh Shekhawat, Maria Theresa Montales, Kevin Kuriakose,[...]. Front Endocrinol (Lausanne) 2017
315
100

A Contemporary Overview of PPARα/γ Dual Agonists for the Management of Diabetic Dyslipidemia.
Pitchai Balakumar, Nanjaian Mahadevan, Ramanathan Sambathkumar. Curr Mol Pharmacol 2019
11
100

Liraglutide vs. lixisenatide in obese type 2 diabetes mellitus patients: What effect should we expect in routine clinical practice?
Jesus Moreno-Fernandez, Jose Alberto Garcia-Seco, Angela Maria Seco Segura, Fernando Garcia-Seco, Pedro Jesus Rozas Moreno, Miguel Aguirre Sanchez-Covisa. Prim Care Diabetes 2020
1
100

An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus.
Daniel S Hsia, Owen Grove, William T Cefalu. Curr Opin Endocrinol Diabetes Obes 2017
96
100

Glucagon-like peptide-1 analogues: An overview.
Vishal Gupta. Indian J Endocrinol Metab 2013
60
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.